Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Patient Preference and Adherence|April 17, 2013
Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophreniaTatiana Dilla, Antonio Ciudad, María Alvarez
Endocrinologia, Diabetes Y Nutricion|December 12, 2018
Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature reviewSilvia Díaz, Tatiana Dilla, Jesus Reviriego
BMC Psychiatry|April 16, 2009
A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in SpainJihyung Hong, Tatiana Dilla, Jorge Arellano
BMC Health Services Research|June 30, 2010
Health economics: the start of clinical freedomJosé Antonio Sacristán, María Costi, Amparo Valladares, et al.
Oncogene|April 12, 2002
The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiationTatiana Dilla, Jesús Romero, Pilar Sanstisteban, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 7, 2018
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in SpainErin Johansson, Mercedes Nuñez, Axel Svedbom, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 21, 2019
Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature ReviewMercedes Núñez, Silvia Díaz, Tatiana Dilla, et al.
Acta Diabetologica|October 27, 2009
Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in SpainMaría Costi, Tatiana Dilla, Jesús Reviriego, et al.
Archivos Espanoles De Urologia|May 9, 2007
[Evaluation of women's preferences for the treatment of stress urinary incontinence using the paired comparisons method]Montserrat Espuña Pons, Pablo Rebollo Alvarez, Montserrat Puig Clota, et al.
The Journal of Mental Health Policy and Economics|August 1, 2015
Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal PerspectiveJohn Hornberger, Steven Michalopoulos, Minghan Dai, et al.
Pageof 4